<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03570164</url>
  </required_header>
  <id_info>
    <org_study_id>2018-05-019</org_study_id>
    <nct_id>NCT03570164</nct_id>
  </id_info>
  <brief_title>Hemodynamics for Equi-MAC Anesthesia</brief_title>
  <official_title>Comparison of Vasodilative Effects Between Sevoflurane and Desflurane Using Peripheral Perfusion Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kangbuk Samsung Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kangbuk Samsung Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the peripheral perfusion index values produced by
      equi-MAC of sevoflurane and desflurane in patients undergoing single-agent inhalation
      anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ether derivative anesthetics, including sevoflurane and desflurane, have direct activity on
      vascular tissue and both are vasodilators. However, there has been no direct comparison of
      vasodilative effect between sevoflurane and desflurane in vivo in humans. Peripheral
      perfusion index derived from photoplethysmographic waveform reflects peripheral vasomotor
      tone. Therefore, the purpose of this study is to compare the peripheral perfusion index
      values produced by sevoflurane and desflurane at equipotent concentration in patients
      undergoing single-agent inhalation anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 18, 2018</start_date>
  <completion_date type="Actual">November 13, 2018</completion_date>
  <primary_completion_date type="Actual">November 13, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>peripheral perfusion index</measure>
    <time_frame>After a 30-min waiting period from the induction of anesthesia</time_frame>
    <description>peripheral perfusion index value at a steady-state anesthesia of age-corrected 1.0 MAC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure</measure>
    <time_frame>After a 30-min waiting period from the induction of anesthesia</time_frame>
    <description>mean arterial pressure at a steady-state anesthesia of age-corrected 1.0 MAC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>After a 30-min waiting period from the induction of anesthesia</time_frame>
    <description>heart rate at a steady-state anesthesia of age-corrected 1.0 MAC</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia is maintained with sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia is maintained with desflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>End-tidal concentration of sevoflurane is maintained at age-corrected 1.0 minimum alveolar concentration throughout the study period.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>End-tidal concentration of desflurane is maintained at age-corrected 1.0 minimum alveolar concentration throughout the study period.</description>
    <arm_group_label>Desflurane</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged between 19 and 65 yr

          -  patients with American Society of Anesthesiologists physical status classification I
             or II

          -  patients scheduled for elective arthroscopic knee surgery under general anesthesia

          -  patients obtaining written informed consent

        Exclusion Criteria:

          -  patients with a history of any disease associated with the autonomic nervous system

          -  patients receiving any medication affecting the sympathetic or parasympathetic nervous
             systems

          -  patients with cardiac arrhythmia, diabetes mellitus, and alcohol or drug abuse

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyoung-Ho Ryu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangbuk Samsung Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 15, 2018</study_first_submitted>
  <study_first_submitted_qc>June 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2018</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kangbuk Samsung Hospital</investigator_affiliation>
    <investigator_full_name>Kyoung-Ho Ryu, MD</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

